A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

Delray Medical Center Becomes first Hospital in South Florida to Use the New Surpass Evolve Flow Diverter for Aneurysms

Delray Medical Center is the first hospital in South Florida to use the Surpass Evolve Flow Diverter for aneurysm patients.  This device is the first 64-wire cobalt chromium flow diverter designed to re-direct blood flow and promote aneurysm healing. Dr. Dennys Reyes is the first surgeon to use this technology. 

Surpass Evolve is a cutting-edge technology that is advancing the frontiers of patient care in aneurysm treatment, “said Dr. Dennys Reyes, neurointerventionalist on staff at Delray Medical Center.  “Treating at risk intracranial aneurysms before they rupture is a focus of our stroke program that can help save lives and provide some of the best care in the community.”

An aneurysm occurs when part of a blood vessel becomes weak, causing the vessel to balloon or bulge and fill with blood. Aneurysms can occur in any blood vessel in the body. However, brain aneurysms are the most life-threatening. If left untreated, the aneurysm may continue to weaken until it bursts and bleeds into the brain. Almost 500,000 deaths occur each year as a result of a brain aneurysm.  

“It has been very rewarding to see technology like this help our patients get neurological care close to home,” said Maggie Gill, chief executive officer of the Palm Beach Health Network and Delray Medical Center. “We continue to see outcomes in patients that could have been avoided if they had come to the hospital sooner and not delayed care.  We have the proper protocols in place to deliver care safely.

Delray Medical Center has the advanced technology and services to help with any neurological issues.  As a member of the Advanced Neuroscience Network, an integrated delivery system of medical professionals and hospitals focused on offering a full continuum of neurological care throughout South Florida, we focus on everything from prevention and diagnosis to treatment and rehabilitation. For more information go to our website at www.delraymedicalctr.com

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy